Can Fite Biopharma
CANF
#11064
Rank
NZ$7.95 M
Marketcap
NZ$2.62
Share price
-2.34%
Change (1 day)
344.49%
Change (1 year)

EPS for Can Fite Biopharma (CANF)

EPS in 2023 (TTM): NZ-$382.33

According to Can Fite Biopharma 's latest financial reports the company's current EPS (TTM) is NZ-$428.06. In 2025 the company made an earnings per share (EPS) of NZ-$19.64 an increase over its 2024 EPS that were of NZ-$35.73.

EPS history for Can Fite Biopharma from 2010 to 2023

Annual EPS

Year EPS Change
2025NZ-$19.64-45.03%
2024NZ-$35.73-39.4%
2023NZ-$58.96-46.24%
2022NZ-$109.68-66.67%
2021NZ-$329.04-25%
2020NZ-$438.72-71.43%
2019NZ-$1,536-17.65%
2018NZ-$1,86511.48%
2017NZ-$1,673-49.17%
2016NZ-$3,29044.58%
2015NZ-$2,276-40.15%
2014NZ-$3,803-43.05%
2013NZ-$6,6779.34%
2012NZ-$6,106-22.1%
2011NZ-$7,83869.04%
2010NZ-$4,637